ACADACADIA PHARMACEUTICALS INC
CUSIP 004225108 · common stock
4 tracked investors held ACADIA PHARMACEUTICALS INC (ACAD) at the end of Q3 2026, worth $881.2M in total. The largest holder was Julian Baker, with 4.1% of its portfolio. Joel Greenblatt opened a new position this quarter.
Holders · Q3 2026
4
New holders
1
Value held
$881.2M
Quarter-end price (est.)
$20.15
Investors holding ACAD · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Julian Baker Baker Bros. Advisors LP | 4.11% | 42,912,904 | $864.7M | HOLD |
| Ken Fisher Fisher Asset Management, LLC | 0.00% | 711,352 | $14.3M | ADD+1.7% |
| Chuck Royce Royce & Associates LP | 0.02% | 93,193 | $1.9M | ADD+1.4% |
| Joel Greenblatt Gotham Asset Management, LLC | 0.00% | 14,788 | $298K | NEW |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Adar1 Capital Management | 0.05% | 38,955 | $985.6K | EXIT |